Bristol-Myers Squibb Company (BMY) Price Forecast — AI Targets | MarketCI

Bristol-Myers Squibb Company (BMY) Price Forecast — AI Targets | MarketCI | MarketCI

BMY

Market Closed

Bristol-Myers Squibb Company

NYSEHealthcare Drug Manufacturers - General

34.10K employees

CEO: Christopher S. Boerner

Founded: 1972

$54.00

+$0.00(+NaN%)

Market Cap

110.27B

Beta

0.24

52W Range

N/A

Dividend Yield

4.63%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Forecasting Analysis

AI-powered predictions and statistical risk modeling for short-term price movements

AI Insight:

Bristol-Myers Squibb's AI 30-day forecast is projecting slight downside risk with weak short-term momentum. Analyst consensus for 12 months shows strong coverage but wide disagreement, indicating uncertainty in long-term valuation. This divergence underscores a mixed risk profile with potential volatility.

Current Price

N/A

Last closing price

Price Prediction

Machine learning prediction based on historical price patterns

Period:

Analyst Price Target for BMY

Loading analyst price targets...

Wall Street Forecasts

Revenue Forecast

Past Growth

N/A

Based on Historical CAGR

Forward Growth

N/A

Projected CAGR

Analyst Accuracy

Estimate Accuracy

Revenue Analysis

Comparison of Actual and Estimated Revenues

Loading chart data...

Revenue growth steady at 0.0%.

Operating Profitability Forecast

Past Growth

N/A

EBITDA Historical CAGR

Forward Growth

N/A

EBITDA Projected CAGR

Analyst Accuracy

Estimate Accuracy

EBITDA Analysis

Comparison of Actual and Estimated EBITDA

Loading chart data...

EBITDA maintaining 0.0% trajectory.

Earnings Per Share Forecast

Past Growth

N/A

EPS Historical CAGR

Forward Growth

N/A

EPS Projected CAGR

Analyst Accuracy

Estimate Accuracy

EPS Analysis

Comparison of Actual and Estimated Earnings Per Share

Loading chart data...

EPS growth stable around 0.0%.

Explore BMY

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

BMY in the Healthcare

Large Cap

Healthcare

Browse sector stocks →

Drug Manufacturers - General

Browse industry stocks →